Search research articles
Contact Us
Filters
Showing results (11-20 of 150) with videos related to
Page
of 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 19, 2019
Evaluations of the Public Health Impact of Adult Vaccination with Pneumococcal Vaccines Should Include Reductions in All-Cause Pneumonia
Christian Theilacker, Andrew Vyse, Luis Jodar, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
April 18, 2023
The Epidemiology of Lyme Borreliosis in Europe: An Updated Review on a Growing Public Health Issue
James H Stark, Andreas Pilz, Luis Jodar, et al.
Plos One
|
September 30, 2021
Burden of invasive group B Streptococcus disease in non-pregnant adults: A systematic review and meta-analysis
Adoración Navarro-Torné, Daniel Curcio, Jennifer C Moïsi, et al.
Open Forum Infectious Diseases
|
July 25, 2022
US County-Level COVID-19 Vaccine Uptake and Rates of Omicron Cases and Deaths
John M McLaughlin, Timothy L Wiemken, Farid Khan, et al.
Microorganisms
|
May 28, 2022
Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). <i>Microorganisms</i> 2022, <i>10</i>, 127
Christian Theilacker, Mark A Fletcher, Luis Jodar, et al.
Microorganisms
|
January 21, 2022
PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
Christian Theilacker, Mark A Fletcher, Luis Jodar, et al.
Human Vaccines
|
April 17, 2008
Cholera vaccines for the developing world
Anna Lena Lopez, John D Clemens, Jacqueline Deen, et al.
Vaccine
|
September 3, 2017
Rethinking number-needed-to-vaccinate for pneumococcal conjugate vaccines in older adults: Current and future implications
John M McLaughlin, David L Swerdlow, Raul E Isturiz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 23, 2017
Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease
Christian Theilacker, Betsy Hilton, Qin Jiang, et al.
The Lancet. Infectious Diseases
|
March 28, 2018
Reassessing the 1 + 1 pneumococcal conjugate vaccine schedule
Raul Isturiz, Bradford D Gessner, Harish Madhava, et al.
Page
of 15
Search research articles
Search
Showing results (11-20 of 150) with videos related to
Sort By:
Page
of 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 19, 2019
Evaluations of the Public Health Impact of Adult Vaccination with Pneumococcal Vaccines Should Include Reductions in All-Cause Pneumonia
Christian Theilacker, Andrew Vyse, Luis Jodar, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
April 18, 2023
The Epidemiology of Lyme Borreliosis in Europe: An Updated Review on a Growing Public Health Issue
James H Stark, Andreas Pilz, Luis Jodar, et al.
Plos One
|
September 30, 2021
Burden of invasive group B Streptococcus disease in non-pregnant adults: A systematic review and meta-analysis
Adoración Navarro-Torné, Daniel Curcio, Jennifer C Moïsi, et al.
Open Forum Infectious Diseases
|
July 25, 2022
US County-Level COVID-19 Vaccine Uptake and Rates of Omicron Cases and Deaths
John M McLaughlin, Timothy L Wiemken, Farid Khan, et al.
Microorganisms
|
May 28, 2022
Correction: Theilacker et al. PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). <i>Microorganisms</i> 2022, <i>10</i>, 127
Christian Theilacker, Mark A Fletcher, Luis Jodar, et al.
Microorganisms
|
January 21, 2022
PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
Christian Theilacker, Mark A Fletcher, Luis Jodar, et al.
Human Vaccines
|
April 17, 2008
Cholera vaccines for the developing world
Anna Lena Lopez, John D Clemens, Jacqueline Deen, et al.
Vaccine
|
September 3, 2017
Rethinking number-needed-to-vaccinate for pneumococcal conjugate vaccines in older adults: Current and future implications
John M McLaughlin, David L Swerdlow, Raul E Isturiz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 23, 2017
Comparing the Impact of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease
Christian Theilacker, Betsy Hilton, Qin Jiang, et al.
The Lancet. Infectious Diseases
|
March 28, 2018
Reassessing the 1 + 1 pneumococcal conjugate vaccine schedule
Raul Isturiz, Bradford D Gessner, Harish Madhava, et al.
Page
of 15